Investigating the effect of education on Multiple Sclerosis patients' drug adherence

Comparing the impact of education based on traditional methods and Planned Behavior Theory on Treatment Adherence in Patients with Multiple Sclerosis Receiving Injectable Immunomodulatory Drugs

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210808052109N1

Enrollment

100

Registered

2021-08-12

Start date

2021-09-06

Completion date

Unknown

Last updated

2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis. Relapsing Remitting Multiple Sclerosis

Interventions

Intervention 1: Intervention group: In addition to routine training, training with the theory of planned behavior will be done based on the initial needs assessment. To transfer the training with the

Eligibility

Sex/Gender

All

Age

20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Relapsing Remitting Multiple Sclerosis Patients Be treated with interferon beta-1a(Rebif) at least one to four years

Exclusion criteria

Exclusion criteria: Patient dissatisfaction to continue participating in the study

Design outcomes

Primary

Measure	Time frame
Determining the effect of education based on the theory of planned behavior on the promotion of drug adherence in patients with multiple sclerosis treated with modulatory drugs, beta 1a interferons, which are injected subcutaneously. Timepoint: Patients are first given a drug compliance questionnaire. Patients are instructed and after three months, a drug compliance questionnaire will be taken from these patients again and the effectiveness of the training will be measured. Method of measurement: To assess adherence to treatment, two questionnaires are used: 1 - Multiple Sclerosis Treatment Adherence Questionnaire 2- Theoretical questionnaire to assess the impact of the curriculum on the structures of the planned behavior theory.	—

Measure

Time frame

Determining the effect of education based on the theory of planned behavior on the promotion of drug adherence in patients with multiple sclerosis treated with modulatory drugs, beta 1a interferons, which are injected subcutaneously. Timepoint: Patients are first given a drug compliance questionnaire. Patients are instructed and after three months, a drug compliance questionnaire will be taken from these patients again and the effectiveness of the training will be measured. Method of measurement: To assess adherence to treatment, two questionnaires are used: 1 - Multiple Sclerosis Treatment Adherence Questionnaire 2- Theoretical questionnaire to assess the impact of the curriculum on the structures of the planned behavior theory.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSara Hamtaei Gashti

Arak University of Medical Sciences

sarah.hamtaee@yahoo.com+98 86 3313 6055

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 9, 2026